Effect of vaccines and antivirals during the major 2009 A(H1N1) pandemic wave in Norway--and the influence of vaccination timing.
To evaluate the impact of mass vaccination with adjuvanted vaccines (eventually 40% population coverage) and antivirals during the 2009 influenza pandemic in Norway, we fitted an age-structured SEIR model using data on vaccinations and sales of antivirals in 2009/10 in Norway to Norwegian ILI survei...
Guardado en:
Autores principales: | Birgitte Freiesleben de Blasio, Bjørn G Iversen, Gianpaolo Scalia Tomba |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/49d191d8c84b45778a95a6a75f441f1a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Meta-analysis of the immunogenicity and tolerability of pandemic influenza A 2009 (H1N1) vaccines.
por: Lamberto Manzoli, et al.
Publicado: (2011) -
Cost-effectiveness of 2009 pandemic influenza A(H1N1) vaccination in the United States.
por: Lisa A Prosser, et al.
Publicado: (2011) -
US public support for vaccine donation to poorer countries in the 2009 H1N1 pandemic.
por: Supriya Kumar, et al.
Publicado: (2012) -
Methicillin-resistant Staphylococcus aureus (MRSA) is increasing in Norway: a time series analysis of reported MRSA and methicillin-sensitive S. aureus cases, 1997-2010.
por: John F Moxnes, et al.
Publicado: (2013) -
Safety of pandemic (H1N1) 2009 monovalent vaccines in taiwan: a self-controlled case series study.
por: Wan-Ting Huang, et al.
Publicado: (2013)